Community Pharmacies

Monica Harding Excerpts

Tuesday 2nd June 2026 Westminster Hall

[Sureena Brackenridge]

I extend my sincere gratitude and congratulations; 75 years working in a pharmacy is incredible. At the other end of the scale from Sadie, my very first Saturday job was in pharmacies in Wednesfield and Willenhall in my constituency. I also extend my thanks to the pharmacies, dispensers, frontline shop staff and delivery drivers whose dedication underpins that support. Community pharmacies are among the most accessible and trusted parts of our NHS.

[Monica Harding (Esher and Walton) (LD)]

Boots closed its pharmacy in Thames Ditton in 2024. An application was put in for another one, but it was decided following a pharmaceutical needs assessment that the need was met by the chemist. However, elderly residents have a 20-minute-plus walk to get to the chemist, and the high street around it has pretty much collapsed. Does the hon. Member agree that, beyond macro PNA figures, local circumstances are relevant?

[Sureena Brackenridge]

I agree. The absence of a community pharmacy leaves a vacuum on the high street that is felt by residents. I am sure that Members across this Chamber will appreciate that factor as well.

Some 1.6 million people walk through a pharmacy door in England every day; they are embedded in our communities. That is why I welcome the Government’s recent £340 million funding agreement for the sector and the expansion of Pharmacy First. It builds on a service that has already delivered more than 3.3 million consultations in the past year alone. Crucially, from autumn 2026, pharmacists with independent prescribing qualifications will be able to assess patients and prescribe medicines directly on the NHS. It is a significant step forward to deliver faster care right on our high street.

However, if we are serious about shifting care into the community, improving prevention and delivering on the ambitions of the NHS 10-year health plan, we must be honest about the challenges that the sector has faced. From 2010 to 2015, community pharmacy funding broadly kept pace with demand, but from 2016 onwards it was cut and then largely held flat in cash terms through 2023 as costs and workload increased. That resulted in a sustained real-terms decline of around 20% to 25%. Since 2024, funding has begun to rise again, but primarily to stabilise the sector after years of underinvestment, with a significant gap still existing between funding and actual costs.

Across England we have lost nearly 1,500 pharmacies since 2017—that is 15% of the entire network. Those national pressures are felt acutely in my constituency of Wolverhampton North East, where, since 2020, we have seen a net loss of six pharmacies. Yet, despite those challenges, my local pharmacies continue to step up. Through Pharmacy First alone, they have delivered more than 23,500 consultations. That points to the scale of the opportunities ahead.

Community pharmacies are central to the future of primary care. It is thought that they could release up to 51 million primary care appointments by doing more on prevention and helping patients to manage long-term conditions. Independent prescribing is a vital part of that vision. At present, many pharmacies derive over 90% of their income from NHS funding while facing rising staff costs and increasing business pressures. The sector has also lost more than 3,000 full-time equivalent pharmacists in recent years. I therefore ask the Minister: what steps will the Government take to provide long-term sustainable funding and a road map for community pharmacies, and how will they address the workforce shortages and challenges?

In Wolverhampton North East, pharmacies have stepped up time and again for local people. Now I stand with my pharmacies to ensure that they can continue to serve my constituents for many years to come.

--- Later in debate ---

[Dr Chambers]

I completely agree. All businesses need predictability and stability. It appears that, week to week, pharmacists are trying to work out how to source drugs with changing prices, and there is an NHS contract that is not meeting their needs.

When we talk about community healthcare and provision, it is important to remember that having good, well-run pharmacies means that people are being kept out of GP practices and that they are less likely to turn up at A&E. That is even better value for money for the NHS and, ultimately, for the taxpayer. There is no downside from a Government point of view to investing and heavily supporting community pharmacy, because the savings made upstream will be hugely significant. At the moment, we are treating people with conditions that should be treated in the community with the most expensive part of the NHS, in A&E and hospital, when they could quite possibly have avoided going there in the first place.

[Monica Harding]

Accessibility is paramount. The costs that are pushed on to pharmacists mean that they cannot remain sustainable and that they resist opening pharmacies in smaller places, because it will take away business from them. Therefore, those pressures take away accessibility, which is needed.

[Dr Chambers]

That is another legitimate point, and it was made in my second to last words, so I thank my hon. Friend for contributing. I thank the Minister for listening to our concerns.